Akeso Announces IND Acceptance for AK139, a Bispecific Antibody Targeting IL-4Rα and ST2 for Respiratory and Skin Diseases ...Middle East

HONG KONG, Feb. 13, 2025 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China National Medical Products Administration (NMPA) for AK139, a bispecific antibody targeting IL-4Rα...

Read More Details
Finally We wish PressBee provided you with enough information of ( Akeso Announces IND Acceptance for AK139, a Bispecific Antibody Targeting IL-4Rα and ST2 for Respiratory and Skin Diseases )

Also on site :

• Meet the Jewish students speaking to US lawmakers about Columbia’s protests
• The treaty that kept India and Pakistan in check is gone. Now what?
• Kremlin comments on ceasefire plans after Ukrainian drone strikes